PRINCETON, N.J., Dec. 01, 2022 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that it will participate in the RHK Capital Disruptive Growth Conference being held in the offices of Reed Smith in New York, NY on December 5-6, 2022. Chairman and Chief Executive Officer Al Altomari will present a corporate overview at the conference on Monday, December 5 at 3:20 p.m. ET.
The RHK Capital Disruptive Growth Conference webcast will be available on the investor relations page of the Company’s website at
https://ir.agiletherapeutics.com/events-and-presentations
. The replay of the webcast will be archived on the website for approximately 30 days.
To learn more or submit a registration request for the conference, visit
http://disruptnyc.com/
.
About
Agile
Therapeutics,
Inc.
Agile Therapeutics is a women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla®, (levonorgestrel and ethinyl estradiol), a transdermal system, is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at
www.agiletherapeutics.com
. The Company may occasionally disseminate material, nonpublic information on the Company’s website, Twitter account (@agilether), and
LinkedIn
account.
Contact:
Matt Riley
Head of Investor Relations & Corporate Communications
[email protected]
